147 related articles for article (PubMed ID: 25644940)
1. A clinicopathological cohort study of liver pathology in 301 patients with human immunodeficiency virus/acquired immune deficiency syndrome.
Sonderup MW; Wainwright H; Hall P; Hairwadzi H; Spearman CW
Hepatology; 2015 May; 61(5):1721-9. PubMed ID: 25644940
[TBL] [Abstract][Full Text] [Related]
2. Liver injury in HIV-1-infected patients receiving non-nucleosides reverse transcriptase inhibitors-based antiretroviral therapy.
Li ZC; Li HJ; Dai LL; Gao YQ; Cai WP; Li HY; Huang XJ; Zhang T; Wu H
Chin Med J (Engl); 2010 Dec; 123(24):3587-90. PubMed ID: 22166636
[TBL] [Abstract][Full Text] [Related]
3. Human Immunodeficiency Virus Infection, Antiretroviral Therapy, and Liver Pathology.
Sonderup MW; Wainwright HC
Gastroenterol Clin North Am; 2017 Jun; 46(2):327-343. PubMed ID: 28506368
[TBL] [Abstract][Full Text] [Related]
4. Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection.
Aranzabal L; Casado JL; Moya J; Quereda C; Diz S; Moreno A; Moreno L; Antela A; Perez-Elias MJ; Dronda F; Marín A; Hernandez-Ranz F; Moreno A; Moreno S
Clin Infect Dis; 2005 Feb; 40(4):588-93. PubMed ID: 15712082
[TBL] [Abstract][Full Text] [Related]
5. Effect of liver fibrosis on long-term mortality in HIV/hepatitis C virus-coinfected individuals who are evaluated to receive interferon therapies in the highly active antiretroviral therapy era.
Sanmartin R; de Felipe E; Tor J; Sanvicens A; Barluenga E; Martinez E; Muga R; Jou A; Ojanguren I; López JJ; Clotet B; Tural C
AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1235-43. PubMed ID: 22443303
[TBL] [Abstract][Full Text] [Related]
6. Managing symptomatic drug-induced liver injury in HIV-hepatitis C virus-coinfected patients: a role for interferon.
McGovern BH; Birch C; Zaman MT; Bica I; Stone D; Quirk JR; Davis B; Zachary K; Basgoz N; Graeme-Cook F; Gandhi RT
Clin Infect Dis; 2007 Nov; 45(10):1386-92. PubMed ID: 17968840
[TBL] [Abstract][Full Text] [Related]
7. The hepatobiliary manifestations of human immunodeficiency virus infection.
Lebovics E; Dworkin BM; Heier SK; Rosenthal WS
Am J Gastroenterol; 1988 Jan; 83(1):1-7. PubMed ID: 3276149
[TBL] [Abstract][Full Text] [Related]
8. Risk and determinants of developing severe liver toxicity during therapy with nevirapine-and efavirenz-containing regimens in HIV-infected patients.
Ena J; Amador C; Benito C; Fenoll V; Pasquau F
Int J STD AIDS; 2003 Nov; 14(11):776-81. PubMed ID: 14624743
[TBL] [Abstract][Full Text] [Related]
9. [Efficiency and safety of antiretroviral treatment among the elderly in Abidjan].
Tanon AK; Binan Y; Minta D; Ehui E; Ouattara I; Mossou C; Kouakou G; Eholié SP; Aoussi E; Bissagnéné E
Mali Med; 2010; 25(1):37-41. PubMed ID: 21441082
[TBL] [Abstract][Full Text] [Related]
10. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection.
Qurishi N; Kreuzberg C; Lüchters G; Effenberger W; Kupfer B; Sauerbruch T; Rockstroh JK; Spengler U
Lancet; 2003 Nov; 362(9397):1708-13. PubMed ID: 14643119
[TBL] [Abstract][Full Text] [Related]
11. Hepatic histopathology and clinical characteristics associated with antiretroviral therapy in HIV patients without viral hepatitis.
Akhtar MA; Mathieson K; Arey B; Post J; Prevette R; Hillier A; Patel P; Ram LJ; Van Thiel DH; Nadir A
Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1194-204. PubMed ID: 18989143
[TBL] [Abstract][Full Text] [Related]
12. Liver injury during highly active antiretroviral therapy: the effect of hepatitis C coinfection.
Bonacini M
Clin Infect Dis; 2004 Mar; 38 Suppl 2():S104-8. PubMed ID: 14986282
[TBL] [Abstract][Full Text] [Related]
13. Treatment outcomes after early initiation of antiretroviral therapy for human immunodeficiency virus-associated tuberculosis.
Chan CK; Wong KH; Leung CC; Tam CM; Chan KC; Pang KW; Chan WK; Mak IK
Hong Kong Med J; 2013 Dec; 19(6):474-83. PubMed ID: 23926173
[TBL] [Abstract][Full Text] [Related]
14. Hcv coinfection, an important risk factor for hepatotoxicity in pregnant women starting antiretroviral therapy.
Snijdewind IJ; Smit C; Godfried MH; Nellen JF; de Wolf F; Boer K; van der Ende ME
J Infect; 2012 Apr; 64(4):409-16. PubMed ID: 22227465
[TBL] [Abstract][Full Text] [Related]
15. Incidence of liver injury after beginning antiretroviral therapy with efavirenz or nevirapine.
Martín-Carbonero L; Núñez M; González-Lahoz J; Soriano V
HIV Clin Trials; 2003; 4(2):115-20. PubMed ID: 12671779
[TBL] [Abstract][Full Text] [Related]
16. Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients.
Neukam K; Mira JA; Ruiz-Morales J; Rivero A; Collado A; Torres-Cornejo A; Merino D; de Los Santos-Gil I; Macías J; González-Serrano M; Camacho A; Parra-García G; Pineda JA;
J Antimicrob Chemother; 2011 Nov; 66(11):2605-14. PubMed ID: 21903660
[TBL] [Abstract][Full Text] [Related]
17. [Hepatotoxicity with antiretroviral therapy. The liver is affected as well].
MMW Fortschr Med; 2002 Apr; 144 Suppl 1():14-5. PubMed ID: 12043064
[No Abstract] [Full Text] [Related]
18. Clinical vignette in antiretroviral therapy: jaundice.
Zell SC
J Int Assoc Physicians AIDS Care (Chic); 2003; 2(4):133-9. PubMed ID: 14986514
[TBL] [Abstract][Full Text] [Related]
19. Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients.
Labarga P; Soriano V; Vispo ME; Pinilla J; Martin-Carbonero L; Castellares C; Casado R; Maida I; Garcia-Gasco P; Barreiro P
J Infect Dis; 2007 Sep; 196(5):670-6. PubMed ID: 17674307
[TBL] [Abstract][Full Text] [Related]
20. HIV-related liver disease: ARV drugs, coinfection, and other risk factors.
Puoti M; Nasta P; Gatti F; Matti A; Prestini K; Biasi L; Carosi G
J Int Assoc Physicians AIDS Care (Chic); 2009; 8(1):30-42. PubMed ID: 19211929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
